USC Study Shows Relationship Between PFAS and Cancer Incidence
Per- and polyfluoroalkyl substances (PFAS, also known as forever chemicals) are used in many different consumer products. They are found in around 45% of the United States’s drinking water supplies. The chemicals are slow to break down and have been linked to medical problems in the past. Earlier this year, the Keck School of Medicine at USC published a study in the Journal of Exposure Science and Environmental Epidemiology that showed communities that are exposed to drinking water contaminated by PFAS suffer a 33% higher incidence of specific cancers. These cancers are kidney cancer, testicular cancer, liver cancer, thyroid cancer, thyroid disease, and ulcerative colitis. If you were diagnosed with cancer and believe it’s related to PFAS drinking water contamination, please call the seasoned Chicago-based lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved. We represent plaintiffs across the country.
Call Moll Law Group About Your PFAS Lawsuit
The study from the Keck School of Medicine of USC is the first to look at cancer and PFAS-contaminated drinking water. It’s an ecological study that deploys large population-level datasets to find patterns of exposure and related risks. They compared two datasets, one related to all cancer cases reported between 2016-2021 and the other covering data from the Environmental Protection Agency (EPA)’s Unregulated Contaminant Monitoring Program on PFAS in drinking water around the United States.
Between 2016-2021, the study found, counties with PFAS-contaminated drinking water had higher incidence of specific cancers—the PFAS-contaminated drinking water is estimated to be involved in 6800 cancer cases every year. There are differences in cancer incidence between the sexes. Males in counties with contaminated water had higher rates of leukemia, urinary system cancers, and brain and soft tissue cancers than males who lived in counties with uncontaminated water. Females had higher rates of thyroid, mouth, throat and soft tissue cancers. Other factors that can influence risk of cancer were controlled for at different levels as well, including age, urbanicity, socioeconomic status, smoking rates, and prevalence of obesity.
Illinois Injury and Mass Tort Lawyer Blog





Two brands of tomatoes from Williams Farms Repack, LLC were recalled in May in 14 states because of the risk of salmonella contamination. A little over a month ago, the recall was elevated to a
When there are a number of different cases pending in various districts against common defendants and featuring common factual and legal issues, it may be appropriate for plaintiffs to seek to have the cases centralized in a single district. When cases are centralized in this way, pretrial proceedings and discovery can be streamlined. Centralization also prevents judges’ inconsistent rulings on various pretrial matters, particularly evidentiary challenges.
The United States Department of Agriculture’s Food Safety and Inspection Service (FSIS)
Recently, on May 29, 2025, the
A
The FDA has warned consumers not to sell, serve or eat the distributor August Egg Company’s brown cage free and brown certified organic chicken eggs—1.7 million of them been
Seasonal allergies are triggered by pollen and blooming flowers and other plants. Allergy symptoms include runny noses, itchy eyes, sneezing, and sometimes coughing. Patients have been prescribed medications, and in some cases, take over-the-counter allergy medication.
On May 1, 2025, SharkNinja Foodi OP Series Multi-Function Pressure Cookers were
Two Alzheimer’s drugs Leqembi and Kisunla were approved by the FDA to treat mild dementia or a pre-Alzheimer’s condition called mild cognitive impairment. Data had suggested that Leqembi could slow cognitive decline in Alzheimer’s patients by five months over a period of 18 months for patients who had only mild symptoms. Two thousand volunteers had agreed to test Leqembi in clinical studies. However, it turns out these drugs may also increase the risk for brain bleeds and swelling in patients with certain genetic profiles—and patients may not have been given